Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Meeting with management

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on May 06, 2022 10:06am

163 Views

Post# 34661835

RE:RE:Meeting with management

Yeah, you are being overly cynical, which I admit is understandable. But we had already voted our shares prior to the meeting. And nothing about the meeting or who we were voting for or against even came up.

Also, I believe there is a very good chance that all of us will be less cynical as the months roll forward. Every action the company is taking highlights that they think they have something in TH-1902 that could be special. If that turns out to be an accurate assessment ontheir part, our collective cynicism will be replaced by joy. Let's hope that is the way it turns out. My impression is it will.

longterm56 wrote: Sorry for being cynical, but I think the "main takeaway" is that they were campaigning for votes for the Board. A meeting with you "along with three other large shareholders" 5 days before the AGM? Seriously?

-LT

SPCEO1 wrote: Along with three other large shareholders, I had a call yesterday afternoon with the CEO, CFO and CMO. I don't have a lot of time right now to summarize it well but it was an encouraging call. On cancer the CMO said the results are tracking close to what they expected from the preclinical work. I will post more later but the main takeaway is that cancer seems to be on a good path.